ImmuCell CorporationICCCNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank93
3Y CAGR+14.1%
5Y CAGR+13.8%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+14.1%/yr
vs +17.2%/yr prior
5Y CAGR
+13.8%/yr
Consistent
Acceleration
-3.1pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$16.20M-12.7%
2024$18.55M+41.9%
2023$13.08M+19.7%
2022$10.92M+3.1%
2021$10.59M+24.9%
2020$8.48M+21.4%
2019$6.98M+20.6%
2018$5.79M+11.2%
2017$5.21M+26.4%
2016$4.12M-